FLARE THERAPEUTICS
Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets for transcription factor regulation to address mutations that cause disease. Our drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.
FLARE THERAPEUTICS
Industry:
Biotechnology Health Care Life Science
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.flaretx.com
Total Employee:
1+
Status:
Active
Contact:
(857) 706-4400
Email Addresses:
[email protected]
Total Funding:
82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Scorpion Therapeutics
Scorpion Therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Treeline Biosciences
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Boxer Capital
Boxer Capital investment in Series A - Flare Therapeutics
Invus
Invus investment in Series A - Flare Therapeutics
Casdin Capital
Casdin Capital investment in Series A - Flare Therapeutics
Nextech Invest
Nextech Invest investment in Series A - Flare Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series A - Flare Therapeutics
Eventide
Eventide investment in Series A - Flare Therapeutics
Key Employee Changes
Official Site Inspections
http://www.flaretx.com
- Host name: 128.73.198.104.bc.googleusercontent.com
- IP address: 104.198.73.128
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Flare Therapeutics"
About - Flare Therapeutics
Acumen and agility. Experience and excitement. Our team ‘brings it’ every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients. Flare …See details»
Join Us - Flare Therapeutics
Patients are at the heart of FlareTx’s purpose. We are their torchbearers – pick up the mantle and light the path ahead. TEND THE FIRE With the right mix of chemistry and care, the smallest of …See details»
Flare Therapeutics - LinkedIn
Flare Therapeutics will be in San Francisco during #JPM25 in January! If you’d like to learn more about FlareTx’s approach to drugging transcription factors to discover precision medicines for ...See details»
Flare Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (857) 706-4400 Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to …See details»
Flare Therapeutics Information - RocketReach
Based on insights from the seminal work of our scientific founders, the FlareTx team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and …See details»
Flare Therapeutics appoints Douglas Manion as CEO
Apr 24, 2024 Cambridge, USA-based biotech Flare Therapeutics (FlareTx) has appointed Douglas Manion as chief executive, effective immediately. ... which will be invaluable as …See details»
Flare Therapeutics Appoints Douglas Manion, M.D., …
Apr 23, 2024 Over the course of his career, he has gained substantial company building and drug development expertise, which will be invaluable as FlareTx continues to grow as an organization and advances its ...See details»
Flare Therapeutics Announces Strategic Discovery Collaboration …
Nov 12, 2024 Collaboration will leverage Flare Therapeutics’ proteomic and mass spectrometry platform and expertise, powered by its proprietary library of electrophilic compounds, to …See details»
Flare Therapeutics - Craft
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer. It engages in drug development to mitigate the harmful effects …See details»
Flare Therapeutics Appoints Amit Rakhit, M.D. as …
Jul 25, 2022 For more information, please visit www.flaretx.com. We invite you to follow us on LinkedIn and @Flaretx. Contacts. Investors: Sarah McCabe Stern Investor Relations, Inc. [email protected].See details»
Flare Therapeutics - Overview, News & Similar companies
Apr 9, 2024 Flare Therapeutics contact info: Phone number: (857) 706-4400 Website: www.flaretx.com What does Flare Therapeutics do? Based in Cambridge, MA, Flare …See details»
Flare Therapeutics Announces Strategic Discovery Collaboration …
Nov 12, 2024 For more information, please visit www.flaretx.com and follow us on LinkedIn. Investors: [email protected] Media: Peg Rusconi [email protected] Deerfield Group. SOURCE …See details»
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as …
Apr 23, 2024 Over the course of his career, he has gained substantial company building and drug development expertise, which will be invaluable as FlareTx continues to grow as an …See details»
Flare Therapeutics - VentureRadar
Similar Companies: Altay Therapeutics USA Privately Held Founded in 2019, Altay Therapeutics develops novel small molecules that inhibit transcription factors that are validated drivers of …See details»
Flare Therapeutics Announces First Patients Dosed in First-in …
Oct 19, 2023 FX-909 is a first-in-class small molecule inhibitor of the PPARG transcription factor for the potential treatment of advanced urothelial carcinomaSee details»
Flare Therapeutics Named to Inc. Magazine’s Annual List of Best ...
May 9, 2023 The organization’s benefits were also audited to determine overall score and ranking. “Being named to Best Workplaces is an honor that only a small fraction of companies …See details»
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as …
Apr 23, 2024 “There has been rapid growth at FlareTx since the company was launched and I am excited for this opportunity to lead such an exceptional and cross-functional team as we …See details»
Science - Flare Therapeutics
Now one of FlareTx’s scientific co-founders, Dr. Rastinejad had elucidated the structural basis for bidirectional tuning of gene regulation by HIF2A using small molecules. The FlareTx team …See details»
Flare Therapeutics Presents FX-909 Phase 1 Dose Escalation and ...
Jan 26, 2024 "FlareTx has built a robust body of preclinical evidence that supports investigation of FX-909 in clinical trials in patients," said Michael L. Meyers, M.D., Ph.D., Chief Medical …See details»